Company Profile For Boston Scientific Corporation

Boston Scientific Corporation (BSX.N) (New York Stock Exchange)

sector: Healthcare · industry: Advanced Medical Equipment ·

As of 25 Nov 2009

8.64USD

Price Change

+0.08

Percent Change

+0.93%

Analyst Recommendations

Overview

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a broad range of interventional medical specialties, including cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation. The Company’s products are offered for sale principally by three dedicated business groups: Cardiac Rhythm Management (CRM); Cardiovascular, including the Cardiovascular, and Neurovascular businesses; Endosurgery, including the Endoscopy and Urology/Gynecology businesses, and Neuromodulation. In December 2008, the Company completed the acquisition of Labcoat, Ltd.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, Boston Scientific Corp.'s revenues increased 1% to $6.11B. Net income decreased 86% to $51M. Revenues reflect higher income from United States segment and a rise in Japan segment income. Net income was offset by a rise in selling, general & administrative expenses, higher research & development expense, an increase in royalty expense and higher litigation related net charges.